Skip to main content
OpenTrials

Clinical trial condition

Recurrent Cancer

Explore clinical trials studying Recurrent Cancer. Study availability and eligibility vary by location and protocol.

26 public trials 9 recruiting studies
Refine in advanced search Browse all conditions

Recurrent Cancer trial results

Recruiting

IMA402 T Cell-Engaging Receptor Molecule (TCER®) in Recurrent and/or Refractory Solid Tumors

NCT05958121

Conditions
Cancer, Disease Attributes, Neoplasms, +6 more
Locations
  • Universitaetsklinikum Heidelberg AöR Heidelberg, Baden-Wurttemberg, Germany
  • Thoraxklinik Heidelberg gGmbH Heidelberg, Baden-Wurttemberg, Germany
  • Universitaetsklinikum Mannheim GmbH Mannheim, Baden-Wurttemberg, Germany
  • Universitaetsklinikum Tuebingen AöR Tübingen, Baden-Wurttemberg, Germany
View all 29 locations
View Trial Details
Recruiting

ACTengine® IMA203/IMA203CD8 as Monotherapy or in Combination With Nivolumab in Recurrent and/or Refractory Solid Tumors

NCT03686124

Conditions
Adnexal Diseases, Cancer, Disease Attributes, +35 more
Locations
  • Stanford Cancer Institute Stanford, California, United States
  • University of Colorado, Anschutz Medical Campus Aurora, Colorado, United States
  • University of Miami Hospital and Clinics Miami, Florida, United States
  • University of Chicago Medical Center Chicago, Illinois, United States
View all 21 locations
View Trial Details
Recruiting

Pembrolizumab, Ibrutinib and Rituximab in PCNSL

NCT04421560

Conditions
Disease Attributes, Neoplasms, Pathologic Processes, +6 more
Locations
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
  • Columbia University Medical Center New York, United States
  • Memorial Sloan Kettering Cancer Center New York, United States
View Trial Details
Recruiting

Optimal Precision TherapIes to CustoMISE Care in Childhood and Adolescent Cancer

NCT06208657

Conditions
Central Nervous System Neoplasms, Childhood Brain Tumor, Childhood Cancer, +18 more
Locations
  • John Hunter Children's Hospital Newcastle, New South Wales, Australia
  • Sydney Children's Hospital, Randwick Sydney, New South Wales, Australia
  • The Children's Hospital at Westmead Sydney, New South Wales, Australia
  • Queensland Children's Hospital Brisbane, Queensland, Australia
View all 14 locations
View Trial Details
Recruiting

PREventing Second Cancers With DOSTARlimab

NCT05855811

Conditions
Disease Attributes, Neoplasms, Neoplasms, Second Primary, +6 more
Locations
  • Centre François Baclesse Caen, France
  • Centre Jean Perrin Clermont-Ferrand, France
  • Centre Léon Bérard Lyon, France
  • Institut Claudius Regaud Toulouse, France
View Trial Details
Not yet recruiting

Symptom Trajectory Approaches to Research

NCT07804875

Conditions
Advanced Cancer, Cancer Treatment, Disease Attributes, +10 more
Locations
  • Children's Hospital Los Angeles Los Angeles, California, United States
  • New York -Presbyterian Morgan Stanley Children's Hospital New York, United States
  • Nationwide Children's Hospital Columbus, Ohio, United States
  • OHSU Doernbecher Children's Hospital Portland, Oregon, United States
View Trial Details

Related conditions